Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C
Authors
Keywords
-
Journal
Vaccine
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.vaccine.2023.10.054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A
- (2022) Li Hao et al. VACCINE
- Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015–2019
- (2021) Ravinder Kaur et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children
- (2021) Ravinder Kaur et al. VACCINE
- Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
- (2020) Naïm Ouldali et al. LANCET INFECTIOUS DISEASES
- Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine
- (2020) Ravinder Kaur et al. VACCINE
- Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation
- (2020) Robert Cohen et al. CLINICAL INFECTIOUS DISEASES
- Streptococcus pneumoniae: transmission, colonization and invasion
- (2018) Jeffrey N. Weiser et al. NATURE REVIEWS MICROBIOLOGY
- Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period
- (2017) Grace M. Lee et al. PEDIATRICS
- Modeling specific antibody responses to natural immunization to predict a correlate of protection against infection before commencing a clinical vaccine trial
- (2017) Anthony Almudevar et al. Human Vaccines & Immunotherapeutics
- Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006–2015
- (2016) Ravinder Kaur et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults
- (2016) Geert Leroux-Roels et al. VACCINE
- Assignment of Weight-Based Antibody Units for Seven Additional Serotypes to a Human Pneumococcal Standard Reference Serum, 007sp
- (2015) D. Goldblatt et al. Clinical and Vaccine Immunology
- PCVs in individuals at increased risk of pneumococcal disease: a literature review
- (2015) Mark A Fletcher et al. Expert Review of Vaccines
- Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children
- (2015) Q Xu et al. Mucosal Immunology
- Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
- (2015) Alassane Dicko et al. Human Vaccines & Immunotherapeutics
- The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development
- (2015) M Nadeem Khan et al. Human Vaccines & Immunotherapeutics
- Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
- (2014) A. Torres et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
- (2014) Nick J Andrews et al. LANCET INFECTIOUS DISEASES
- Pneumococcal vaccine and opsonic pneumococcal antibody
- (2013) Joon Young Song et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Acute Otitis Media Otopathogens during 2008-2010 in Rochester NY
- (2013) Janet R. Casey et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines
- (2012) T. Q. Tan CLINICAL MICROBIOLOGY REVIEWS
- Antibody response toStreptococcus pneumoniaeproteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children
- (2012) Michael E. Pichichero et al. Human Vaccines & Immunotherapeutics
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Streptococcus pneumoniae: virulence factors and variation
- (2010) A.M. Mitchell et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Streptococcus pneumoniae Capsule Is Required for Full Virulence in Pneumococcal Endophthalmitis
- (2010) M. E. Sanders et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
- (2009) S. S. Huang et al. PEDIATRICS
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now